BioRestorative Therapies Files Q1 2025 10-Q
Ticker: BRTX · Form: 10-Q · Filed: May 14, 2025 · CIK: 1505497
Sentiment: neutral
Topics: 10-Q, quarterly-report, healthcare
Related Tickers: BRTX
TL;DR
BRTX filed Q1 10-Q. Financials updated.
AI Summary
BioRestorative Therapies, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Stem Cell Assurance, Inc., is involved in health and allied services. Their principal executive offices are located at 40 Marcus Drive, Melville, NY 11747.
Why It Matters
This filing provides investors with an update on BioRestorative Therapies' financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a standard quarterly filing with no immediate red flags or significant new information presented.
Key Players & Entities
- BioRestorative Therapies, Inc. (company) — Filer of the 10-Q
- Stem Cell Assurance, Inc. (company) — Former name of BioRestorative Therapies, Inc.
- 40 Marcus Drive, Melville, NY 11747 (location) — Business and mailing address
- 20250331 (date) — End of the reporting period
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the first quarter of 2025, ending on March 31, 2025.
What was BioRestorative Therapies, Inc. formerly known as?
BioRestorative Therapies, Inc. was formerly known as Stem Cell Assurance, Inc.
Where is BioRestorative Therapies, Inc. located?
The company's business and mailing address is 40 Marcus Drive, Melville, NY 11747.
What is the SEC file number for BioRestorative Therapies, Inc.?
The SEC file number for BioRestorative Therapies, Inc. is 001-37603.
When was this 10-Q form filed?
This 10-Q form was filed on May 14, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding BioRestorative Therapies, Inc. (BRTX).